Neuland Laboratories Ltd. (NEULANDLAB): Neuland Laboratories Share Price Hits Fresh 52-Week High

Neuland Laboratories Share Price stood at Rs 23,331.20, up 0.47% today, after hitting a fresh 52-week high of Rs 23,561.55. Market capitalisation stands at Rs 28,874.43 crore.

Neuland Laboratories Share Price is at Rs 23,331.20 on 14 August 2026, up Rs 109.05 or 0.47% for the day, after touching a fresh 52-week high of Rs 23,561.55. The company’s market capitalisation stands at Rs 28,874.43 crore, putting the move firmly on the radar for investors tracking one-year high stocks and fresh market movers in the Indian stock market.

The supplied data confirms the price event clearly: the stock opened at Rs 23,099.95, traded between Rs 23,080.65 and Rs 23,561.55, and moved above its previous close of Rs 23,222.15. Turnover for the session stood at Rs 3.43 crore with current volume of 1,471 shares. That combination makes this Neuland Laboratories Share Price update relevant not because of an established company-specific trigger, but because the verified numbers show a live breakout to a yearly high.

For readers searching Neuland Laboratories Share Price Today, Neuland Laboratories Stock News, or why the stock is trending, the immediate answer is factual: the share has set a new 52-week peak and is trading above the previous close with a positive intraday range. Univest notes that the supplied data establishes the price action, valuation snapshot and sector context, which are the key points investors can monitor next.

Neuland Laboratories Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 23,331.2
Previous Close	Rs 23,222.15
Today's Change	+Rs 109.05 (+0.47%)
Day Open	Rs 23,099.95
Fresh 52-Week High	Rs 23,561.55
Day Low	Rs 23,080.65
Current Volume	1,471
Turnover	Rs 3.43 crore
Market Capitalisation	Rs 28,874.43 crore

Neuland Laboratories Ltd. (NEULANDLAB) traded at Rs 23,331.2. versus the previous close of Rs 23,222.15, a rise of 0.47%. The stock opened at Rs 23,099.95, reached Rs 23,561.55, touched Rs 23,080.65. Reported volume was 1,471.

Neuland Laboratories Share Price Today shows a positive session with the stock holding gains after recording a fresh 52-week high. The move from the previous close to the intraday peak, alongside turnover of Rs 3.43 crore and volume of 1,471 shares, confirms active trading interest in the counter.

From a pure price-action perspective, the stock started the day at Rs 23,099.95 versus a previous close of Rs 23,222.15. It then moved within an intraday band of Rs 23,080.65 to Rs 23,561.55 before trading at Rs 23,331.20 at the time of the event. That leaves the stock higher by Rs 109.05, or 0.47%, on the day.

The fresh 52-week high of Rs 23,561.55 is the central data point in this Neuland Laboratories Share Price update. It indicates that the stock has pushed to a new one-year high during today’s session, even though it is trading below the intraday top at the current price. In practical terms, that means traders and longer-term market participants are both likely to track whether the stock can sustain levels near this 52-week peak or whether intraday volatility becomes more visible.

Today’s range also matters. The spread between the day low of Rs 23,080.65 and the day high of Rs 23,561.55 shows a wide intraday movement of Rs 480.90, which is notable relative to the day’s net gain. In Stock Market Today conditions, such a range often puts a stock into the broader market news flow even without a confirmed company-specific catalyst.

For investors following Neuland Laboratories Share Price Live and Neuland Laboratories Share News, the verified takeaway is simple: the share recorded a fresh yearly high, remained in positive territory against the previous close, and generated Rs 3.43 crore in turnover. The next step is to examine whether the valuation and financial profile strengthen or complicate the current attention.

Neuland Laboratories Ltd. (NEULANDLAB) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 28,874.43 crore
P/E Ratio	31.94x
P/B Ratio	0.47x
ROE	-2.89%
ROCE	-0.26%

Neuland Laboratories Ltd. was valued at a P/E ratio of 31.94x, a P/B ratio of 0.47x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of -2.89% and ROCE of -0.26%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Benchmark Scope	same sector
Company P/E Ratio	31.94x
Benchmark Median P/E	21.38x
Benchmark Average P/E	59.96x
Benchmark P/E Range	0x to 3,299.57x
Company P/B Ratio	0.47x
Benchmark Median P/B	1.95x
Company ROE	-2.89%
Benchmark Median ROE	10.92%
Company ROCE	-0.26%
Benchmark Median ROCE	13.29%
Company Market Capitalisation	Rs 28,874.43 crore
Benchmark Median Market Cap	Rs 141.55 crore

Neuland Laboratories Ltd. (NEULANDLAB) is classified under sector: Healthcare.

Neuland Laboratories Ltd. (NEULANDLAB) has a P/E ratio of 31.94x, which is above the benchmark median of 21.38x, a difference of +49.39%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Neuland Laboratories Ltd. (NEULANDLAB) has a ROE of -2.89%, which is below the benchmark median of 10.92%, a difference of -126.47%. Neuland Laboratories Ltd. (NEULANDLAB) has a ROCE of -0.26%, which is below the benchmark median of 13.29%, a difference of -101.96%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Dishman Carbogen Amcis Ltd.	DCAL	2,995.34	31.94	0.47	-2.89	-0.26
Beta Drugs Ltd.	BETA	2,836.87	69.35	10.97	18.65	22.17
Dr Agarwals Eye Hospital Ltd.	DRAGARWQ	2,644.55	34.7	7.15	-2.6	16.92
Ind-Swift Laboratories Ltd.	INDSWFTLAB	2,605.37	45.02	1.73	-0.78	8.31
Sai Parenteral's Ltd.	SAIPARENT	2,441.79	174.73	3.19	13.9	12.97

Neuland Laboratories Ltd. (NEULANDLAB) has a P/E ratio of 31.94x compared with the displayed peer median of 45.02x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -2.89% compares with a peer median of -0.78% across the companies shown in the table. ROCE stood at -0.26% versus the displayed peer median of 12.97%, providing a capital-efficiency comparison. Neuland Laboratories Ltd. (NEULANDLAB) has a market capitalisation of Rs 28,874.43 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

Why Investors Are Watching Neuland Laboratories

The stock is drawing attention because a verified market event has occurred and the broader context is unusually mixed. For market participants, that combination often keeps a stock in focus beyond the first headline.

• Fresh 52-week high: the stock touched Rs 23,561.55 and is trading at Rs 23,331.20, up 0.47% on the day.
• Active session: turnover stands at Rs 3.43 crore with current volume of 1,471 shares.
• Large size: market capitalisation is Rs 28,874.43 crore, much higher than the supplied sector benchmark median and average.
• Valuation context: P/E is 31.94 and P/B is 0.47, creating a mixed valuation picture against Healthcare benchmarks.
• Profitability context: ROE of -2.89 and ROCE of -0.26 are below the sector median and average figures in the supplied data.
• Sector relevance: the move stands out within a Healthcare benchmark universe of 196 companies tracked in the same sector snapshot.

About Neuland Laboratories

Neuland Laboratories Ltd. is a listed Indian company tracked by Univest under the symbol NEULANDLAB. In the supplied dataset, it is classified within the Healthcare sector, which places it alongside pharmaceutical, drug and healthcare-service businesses for comparative analysis.

Because the verified data for this article is focused on market, valuation and sector metrics, the clearest company context available here is how the stock sits within Healthcare screens and peer sets. The comparison group supplied for this update includes companies such as Dishman Carbogen Amcis, Beta Drugs, Ind-Swift Laboratories and other healthcare names, which helps frame how Neuland Laboratories Share Price is being evaluated by the market today.

For readers looking at Neuland Laboratories Company News or Neuland Laboratories Earnings-related searches, the current article is centred on the fresh 52-week high event and the stock’s present valuation and return profile. Univest therefore treats this as a factual market update driven by verified screener data rather than a broader business-profile note.

Track Neuland Laboratories Share Price on Univest

Use Neuland Laboratories Ltd. (NEULANDLAB) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Investors following Neuland Laboratories Share Price can track the latest share price, 52-week levels, valuation ratios, market capitalisation and peer comparisons on Univest. The platform also helps users monitor daily stock updates, price action, sector context and other verified market insights in one place.

For anyone searching Neuland Laboratories Share Price Today or Neuland Laboratories Stock News, Univest provides a structured way to follow live market data, compare the stock with Healthcare peers and review how fresh 52-week high events fit into broader stock analysis. That makes it easier to track the numbers that matter without turning a price event into a prediction.

Frequently Asked Questions

What is the current Neuland Laboratories Share Price?

Ans. Neuland Laboratories Share Price was Rs 23,331.20 at the time of this update on 14 August 2026. The stock was trading Rs 109.05 higher than its previous close of Rs 23,222.15, reflecting a 0.47% daily gain.

Did Neuland Laboratories hit a fresh 52-week high today?

Ans. Yes, the stock hit a fresh 52-week high of Rs 23,561.55 during the session. It later traded at Rs 23,331.20, which still kept the share above the previous close and in positive territory for the day.

Why is Neuland Laboratories Share Price rising today?

Ans. The supplied data confirms that the stock rose 0.47% and touched a fresh one-year high of Rs 23,561.55. However, the verified figures establish the price event itself and do not identify any company-specific catalyst behind the move.

What were the day open, high and low for Neuland Laboratories today?

Ans. Neuland Laboratories opened at Rs 23,099.95, touched an intraday high of Rs 23,561.55 and a low of Rs 23,080.65. That trading band shows an intraday range of Rs 480.90 in today’s session.

What is the market capitalisation of Neuland Laboratories?

Ans. The company’s market capitalisation is Rs 28,874.43 crore in the supplied dataset. That is far above the Healthcare sector benchmark median market cap of Rs 141.55 crore and also above the benchmark average of Rs 465.17 crore.

What do the valuation ratios of Neuland Laboratories show?

Ans. The stock is trading at a P/E ratio of 31.94 and a P/B ratio of 0.47. Its P/E is above the Healthcare sector median of 21.38, while its P/B is below the sector median of 1.95.

How profitable is Neuland Laboratories based on the supplied ratios?

Ans. The supplied profitability ratios are weak, with ROE at -2.89 and ROCE at -0.26. Both figures are below the Healthcare sector median levels of 10.92 for ROE and 13.29 for ROCE.

How does Neuland Laboratories compare with its peers?

Ans. In the supplied peer set, Neuland Laboratories has a much larger market capitalisation at Rs 28,874.43 crore. Its P/E of 31.94 is below several peers, while its ROE of -2.89 and ROCE of -0.26 are weaker.

What was the trading volume and turnover in Neuland Laboratories today?

Ans. Current trading volume stood at 1,471 shares, while turnover was Rs 3.43 crore. Those figures show that the fresh 52-week high was recorded alongside measurable market participation during the session.

What should investors monitor next in Neuland Laboratories?

Ans. Investors may monitor whether the stock sustains levels near the fresh 52-week high of Rs 23,561.55, while also tracking valuation at 31.94 times earnings and the current profitability ratios of -2.89 ROE and -0.26 ROCE.